isn't a product that treats non inflammatory lesions with no side effects worth people using anyway? I would have thought if they stop them from developing then this is a useful product regardless of the impact on inflammatory ones???
- Forums
- ASX - By Stock
- BOT: Moving Forward
isn't a product that treats non inflammatory lesions with no...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.3¢ |
Change
-0.008(1.97%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.5¢ | 38.0¢ | 35.0¢ | $3.618M | 9.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 33543 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 281074 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 68424 | 0.370 |
14 | 377247 | 0.365 |
11 | 387994 | 0.360 |
10 | 683992 | 0.355 |
11 | 736727 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 280041 | 10 |
0.380 | 495466 | 19 |
0.385 | 307424 | 9 |
0.390 | 723886 | 12 |
0.395 | 352644 | 12 |
Last trade - 15.31pm 15/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online